Rohit Mistry
Impact in
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
-
- Breast Cancer Treatment Studies
- Protease and Inhibitor Mechanisms
Papers in
-
- Advanced Breast Cancer Therapies 7
- Co-authors
- Hazel M. Dockrell (2 shared papers)Ken Duncan (2 shared papers)Jacqueline M. Cliff (2 shared papers)Christopher L. Clayton (2 shared papers)Pauline T. Lukey (2 shared papers)Paul D. van Helden (1 shared paper)Don Wallace (1 shared paper)Nulda Beyers (1 shared paper)
- Journals
- Value in Health (5 papers)Journal of Applied Microbiology (2 papers)Journal of Molecular Diagnostics (1 paper)Journal of Managed Care & Specialty Pharmacy (1 paper)Biochemical Journal (1 paper)
- Partner nations
- United KingdomUnited StatesIndia
In The Last Decade
Rohit Mistry
31 papers receiving 339 citations
Peers
Comparison fields: 5 of 76
- Infectious Diseases 117
- Cancer Research 54
- Epidemiology 115
- Genetics 32
- Immunology 55
Countries citing papers authored by Rohit Mistry
This map shows the geographic impact of Rohit Mistry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rohit Mistry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rohit Mistry more than expected).
Fields of papers citing papers by Rohit Mistry
This network shows the impact of papers produced by Rohit Mistry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rohit Mistry. The network helps show where Rohit Mistry may publish in the future.
Co-authors
The 25 scholars most cited alongside Rohit Mistry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 107 | |
| 2 | 2018 | 67 | |
| 3 | 2004 | 22 | |
| 4 | 1991 | 17 | |
| 5 | 2009 | 17 | |
| 6 | 2004 | 14 | |
| 7 | 2019 | 12 | |
| 8 | 2005 | 11 | |
| 9 | 2022 | 11 | |
| 10 | 2010 | 10 | |
| 11 | 2013 | 7 | |
| 12 | 2018 | 7 | |
| 13 | Budget Impact of Omadacycline for the Treatment of Patients with Community-Acquired Bacterial Pneumonia in the United States from the Hospital Perspective. | 2019 | 7 |
| 14 | 1997 | 5 | |
| 15 | 2012 | 4 | |
| 16 | 2021 | 3 | |
| 17 | 2021 | 3 | |
| 18 | 2020 | 3 | |
| 19 | Budget Impact Model of Omadacycline on Replacing a Proportion of Existing Treatment Options Among Patients Who Present to the Emergency Department with Acute Bacterial Skin and Skin Structure Infections. | 2019 | 3 |
| 20 | 2017 | 2 |
About Rohit Mistry
Rohit Mistry is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Surgery, Molecular Biology and Oncology, having authored 35 papers that have together received 347 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (7 papers), Dental Implant Techniques and Outcomes (4 papers), Antibiotic Use and Resistance (3 papers), Protease and Inhibitor Mechanisms (3 papers), Nosocomial Infections in ICU (2 papers), HER2/EGFR in Cancer Research (2 papers), Viral Infections and Immunology Research (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Infectious Diseases (117 citations), Cancer Research (54 citations), Epidemiology (115 citations), Genetics (32 citations) and Immunology (55 citations). Rohit Mistry has collaborated with scholars based in United Kingdom, United States and India. Frequent co-authors include Hazel M. Dockrell, Ken Duncan, Jacqueline M. Cliff, Christopher L. Clayton, Pauline T. Lukey, Paul D. van Helden, Don Wallace, Nulda Beyers, Gaurav Suri and Kate Young. Their work appears in journals such as Value in Health, Journal of Applied Microbiology, Journal of Molecular Diagnostics, Journal of Managed Care & Specialty Pharmacy and Biochemical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.